%0 Case Reports
%T Agoraphobia and panic attacks complicated by primary aldosteronism improved by treatment with eplerenone: a case report.
%A Kijima R
%A Tesen H
%A Igata R
%A Okamoto N
%A Yoshimura R
%J BMC Psychiatry
%V 23
%N 1
%D 2023 10 27
%M 37891534
%F 4.144
%R 10.1186/s12888-023-05275-w
%X Primary aldosteronism (PA) is an adrenal gland disease, that induces increased secretion of the mineralocorticoid, aldosterone, resulting in symptoms such as hypertension. This study reports a patient with agoraphobia and panic attacks, associated with PA. This patient's psychiatric symptoms improved after treatment with eplerenone, a mineralocorticoid receptor antagonist.<BR>The patient was a 40-year-old female with agoraphobia, which refers to the irrational fear of situations that may cause anxiety, and panic attacks characterized by profuse sweating, palpitations, and generalized weakness. She was diagnosed with hypertension from PA. Subsequently, she received treatment with eplerenone, which improved her agoraphobia and panic attacks.<BR>There have been no previous reports on PA associated with agoraphobia and panic attacks that improved with pharmacotherapy. Patients with agoraphobia and panic attacks should be evaluated for PA. In patients with PA, pharmacotherapy with eplerenone should be considered.